With regards to ovarian clear cell carcinomas, the screening for mutations in the genes of ARID1A, PIK3CA, and ZNF217, can be judged as an inadequate prognostic marker [88-91]. This evidence concerns the gene ARID1A and ovarian clear cell cancer.